Breaking the Shield: How a Novel Mitochondrial Target and a Modified Antibiotic Offer New Hope in the Battle Against Mesothelioma
Executive Overview Malignant mesothelioma remains one of the most formidable adversaries in modern oncology. Caused predominantly by occupational and environmental exposure to asbestos, this rare and aggressive cancer traces its…